Market Place
Sourcing Support
Asana Bio Begins Dosing in Phase 1 Trial of ASN004
08 Apr 2022 //
BUSINESSWIRE
Asana to Present Additional Efficacy Data from Chronic Hand Eczema Phase 2b
22 Apr 2021 //
BUSINESSWIRE
Asana BioSciences to Present Additional Efficacy Data from Chronic Hand Eczema
22 Apr 2021 //
BUSINESSWIRE
Asana BioSciences’ Gusacitinib Granted FDA Fast-Track Designation for Moderate
03 Feb 2021 //
BUSINESSWIRE
Asana BioSciences to Present Clinical Data on Oral ASN007, A Novel ERK1/2
22 Oct 2020 //
BIOSPACE
Asana to Present Positive Results from Ph2b Study of Oral JAK/SYK Gusacitinib
20 Oct 2020 //
BIOSPACE
Asana BioSciences Announces +ve Topline Results Ph2b Study Oral Gusacitinib
02 Jun 2020 //
TYAHOO
Asana BioSciences Announces Topline result Ph2b Study Oral JAK/SYK Gusacitinib
02 Jun 2020 //
BUSINESSWIRE
Asana BioSciences Announce ASN008 Achieves Positive Results
10 Mar 2020 //
BUSINESS WIRE
Amedisys acquires Asana Hospice
26 Nov 2019 //
SEEKING ALPHA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.